Last updated on February 2018

ALXN1210 Versus Eculizumab in Complement Inhibitor Treatment-Na ve Adult Patients With Paroxysmal Nocturnal Hemoglobinuria (PNH)


Brief description of study

The purpose of this study is to assess ALXN1210 compared to eculizumab in adult patients with PNH who have not previously used a complement inhibitor.

Clinical Study Identifier: NCT02946463

Contact Investigators or Research Sites near you

Start Over

Clinical Trial Site

Whittier, CA United States

Clinical Trial Site

Toronto, Canada

Clinical Trial Site

Bogotá, Colombia

Clinical Trial Site

Cali, Colombia

Clinical Trial Site

Medellín, Colombia

Clinical Trial Site

Tallinn, Estonia

Clinical Trial Site

Poitiers, France

Clinical Trial Site

Montpellier, France

Clinical Trial Site

Paris, France

Clinical Trial Site

Essen, Germany

Clinical Trial Site

Ulm, Germany

Clinical Trial Site

Napoli, Italy

Clinical Trial Site

Ogaki, Japan

ClinicalTrial Site

Kanazawa, Japan

Clinical Trial Site

Koshigaya, Japan

Clinical Trial Site

Shinjuku, Japan

Recruitment Status: Closed


Brief Description Eligibility Contact Research Team


Receive Emails About New Clinical Trials!

Sign up for our FREE service to receive email notifications when clinical trials are posted in the medical category of interest to you.